Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWB7 | ISIN: FR0010417345 | Ticker-Symbol: DBV
Tradegate
01.04.25
13:35 Uhr
1,238 Euro
+0,056
+4,74 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
DBV TECHNOLOGIES SA Chart 1 Jahr
5-Tage-Chart
DBV TECHNOLOGIES SA 5-Tage-Chart
RealtimeGeldBriefZeit
1,1381,14616:44
1,1301,14616:44

Aktuelle News zur DBV TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoDBV Technologies S.A. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
MoDBV Technologies S.A. - 8-K, Current Report1
FrWhy DBV Technologies (DBVT) Stock Is Skyrocketing6
FrDBV Technologies announces up to $307M financing to advance Viaskin Peanut program13
FrDBV Technologies S.A.: DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved428Châtillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission...
► Artikel lesen
25.03.DBV Technologies: Herausforderungen und Chancen im aktuellen Marktumfeld6
24.03.DBV Technologies faces cash shortage, stock drops4
24.03.DBV Technologies S.A. - 8-K, Current Report19
DBV TECHNOLOGIES Aktie jetzt für 0€ handeln
24.03.DBV Technologies S.A.: DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin Peanut Patch in 4-7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Res419Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut Patch in 4 - 7-year-olds...
► Artikel lesen
25.02.DBV Technologies S.A.: DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress395Châtillon, France, February 25, 2025 DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT),...
► Artikel lesen
18.02.DBV Technologies stock holds firm with $10 target from JMP15
13.01.DBV Technologies S.A.: Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF387AMF Regulated InformationChâtillon, France, January 13, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV - ISIN: FR0010417345...
► Artikel lesen
08.01.DBV Technologies S.A. - 8-K, Current Report6
08.01.DBV Technologies S.A.: DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study520Châtillon, France, January 8th, 2025 DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in...
► Artikel lesen
18.12.24DBV Technologies S.A. - 8-K, Current Report1
12.12.24Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket4
11.12.24DBV Technologies S.A.: DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin Peanut Patch in Toddlers 1 - 3 Years-Old397Châtillon, France, December 11th, 2024 DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 - 3 Years-Old DBV and FDA aligned on...
► Artikel lesen
11.12.24DBV Technologies S.A. - 8-K, Current Report2
02.12.24DBV Technologies S.A.: Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024357Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market...
► Artikel lesen
11.11.24DBV Technologies S.A.: DBV Technologies Announces Plan to Implement ADS Ratio Change347Châtillon, France, November 11, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT-CUSIP: 23306J200)...
► Artikel lesen
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1